NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









inne

inne

Private
BerlinHealthcare & Life Scienceshttps://inne.io/

Last Round

Series A

Extension

May 25, 2022

Total Funding Raised

$18.9M

Company Overview

inne is a healthtech company that provides an at-home fertility monitoring system using saliva-based biosensors to track hormone levels.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Health IoT, Subscription Commerce, Sensors

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

femtechfertility monitoringhormone-free contraceptionat-home diagnosticsprogesterone testingnatural family planningcycle trackingbiosensorovulation trackerD2C healthhealth IoTsubscription commercedigital healthperiod trackerfertility awareness method

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

inne Comparables

Compare inne with similar companies based on industry and business-model similarity.

inne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

inne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 25, 2022
Series AOct 31, 2019

Key People

Founding team and executive leadership

Eirini Rapti

Co-Founder, CEO

Founding Team

Hicham J. Ratnani

Co-CEO

Executive Team

inne Investors

Notable investors and investment history

inne investors
InvestorRounds
Blossom CapitalSeries A
Calm/Storm VenturesSeries A Extension
Monkfish EquitySeries A
DSM VenturingSeries A Extension
StartGreen CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Saliva-based contraceptive method certified under IVDR in 2025.

inne Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

inne Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about inne's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range183
Year Founded2016
Last FundingMay 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.